Ken Yamaguchi

13.5k total citations · 4 hit papers
312 papers, 9.5k citations indexed

About

Ken Yamaguchi is a scholar working on Oncology, Molecular Biology and Reproductive Medicine. According to data from OpenAlex, Ken Yamaguchi has authored 312 papers receiving a total of 9.5k indexed citations (citations by other indexed papers that have themselves been cited), including 102 papers in Oncology, 87 papers in Molecular Biology and 59 papers in Reproductive Medicine. Recurrent topics in Ken Yamaguchi's work include Ovarian cancer diagnosis and treatment (49 papers), Endometrial and Cervical Cancer Treatments (32 papers) and Cancer Immunotherapy and Biomarkers (31 papers). Ken Yamaguchi is often cited by papers focused on Ovarian cancer diagnosis and treatment (49 papers), Endometrial and Cervical Cancer Treatments (32 papers) and Cancer Immunotherapy and Biomarkers (31 papers). Ken Yamaguchi collaborates with scholars based in Japan, United States and United Kingdom. Ken Yamaguchi's co-authors include Masaki Mandai, Junzo Hamanishi, Noriomi Matsumura, Tsukasa Baba, Ikuo Konishi, Kaoru Abiko, Ryusuke Murakami, Naoki Horikawa, Toshihiko Tsukada and Kenji Takakura and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Ken Yamaguchi

291 papers receiving 9.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Programmed cell death 1 ligand 1 and tumor-infiltrating CD8 ⁺ T lymphocytes are prognostic factors of human ovarian cancer

2007 1.2k citations Junzo Hamanishi, Masaki Mandai et al. Proceedings of the National Academy of Sciences profile →
IFN-γ from lymphocytes induces PD-L1 expression and promotes progression of ovarian cancer

2015 572 citations Kaoru Abiko, Noriomi Matsumura et al. profile →
Chemotherapy Induces Programmed Cell Death-Ligand 1 Overexpression via the Nuclear Factor-κB to Foster an Immunosuppressive Tumor Microenvironment in Ovarian Cancer

2015 437 citations Peng Jin, Junzo Hamanishi et al. Cancer Research profile →
Tumor Immune Microenvironment during Epithelial–Mesenchymal Transition

2021 227 citations Mana Taki, Kaoru Abiko et al. Clinical Cancer Research profile →

Peers

Countries citing papers authored by Ken Yamaguchi

Since Specialization

Citations

This map shows the geographic impact of Ken Yamaguchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ken Yamaguchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ken Yamaguchi more than expected).

Fields of papers citing papers by Ken Yamaguchi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ken Yamaguchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ken Yamaguchi. The network helps show where Ken Yamaguchi may publish in the future.

Co-authorship network of co-authors of Ken Yamaguchi

This figure shows the co-authorship network connecting the top 25 collaborators of Ken Yamaguchi. A scholar is included among the top collaborators of Ken Yamaguchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ken Yamaguchi. Ken Yamaguchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Molecular features and prognostic factors of locally advanced microsatellite instability-high gastric cancer 2024 ·Gastric Cancer ·(unknown), Keiichi Hatakeyama, Masanori Terashima, Kenichi Urakami, (unknown), Keiichi Fujiya, Yutaka Tanizawa, Etsuro Bando, Ken Yamaguchi	2
2	In VivoAntitumor Activity of the PD-1/PD-L1 Inhibitor SCL-1 in Various Mouse Tumor Models 2024 ·In Vivo ·Tadashi Ashizawa, Akira Iizuka, (unknown), Takayuki Ando, (unknown), Haruo Miyata, (unknown), (unknown), Yasufumi Kikuchi, Kouji Maruyama, Takeshi Nagashima, Kenichi Urakami, Ken Yamaguchi, Yasuto Akiyama	0
3	Administration of carperitide in cases of pulmonary edema with preeclampsia: a pilot case series 2024 ·(unknown), Yoshitsugu Chigusa, Ken Yamaguchi, (unknown), (unknown), Makiko Morita, Masaki Mandai, (unknown)	1
4	A Deep Learning–Based Assessment Pipeline for Intraepithelial and Stromal Tumor-Infiltrating Lymphocytes in High-Grade Serous Ovarian Carcinoma 2024 ·American Journal Of Pathology ·(unknown), Ryusuke Murakami, Akihiko Ueda, (unknown), (unknown), Mana Taki, Koji Yamanoi, Ken Yamaguchi, Junzo Hamanishi, Sachiko Minamiguchi, Noriomi Matsumura, Masaki Mandai	4
5	Temperature-Induced Lattice Defects and Surface Reconstruction in BaTiO₃ Nanocubes 2024 ·Chemistry of Materials ·Kouichi Nakashima, (unknown), (unknown), (unknown), (unknown), T. Kobayashi, Ken Yamaguchi, (unknown)	1
6	Genetic and Immunological Characterization of Brain Metastases from Solid Cancers 2024 ·Anticancer Research ·Shoichi Deguchi, Yasuto Akiyama, Koichi Mitsuya, (unknown), (unknown), Akira Iizuka, Haruo Miyata, (unknown), Tadashi Ashizawa, Takeshi Nagashima, Kenichi Urakami, Keiichi Ohshima, Koji Muramatsu, Takashi Sugino, Yasuhisa Ohde, Yasuhiro Tsubosa, Seiichiro Nishimura, Ken Yamaguchi	1
7	YAP1 Suppression by ZDHHC7 Is Associated with Ferroptosis Resistance and Poor Prognosis in Ovarian Clear Cell Carcinoma 2024 ·Molecular Cancer Therapeutics ·(unknown), Ken Yamaguchi, Koji Yamanoi, (unknown), Shiro Takamatsu, Mana Taki, Masayo Ukita, Yuko Hosoe, Ryusuke Murakami, Kaoru Abiko, Akihito Horie, Junzo Hamanishi, Tsukasa Baba, Noriomi Matsumura, Masaki Mandai	7
8	Comprehensive sequencing of circulating tumour DNA in resectable pancreatic cancer 2024 ·British journal of surgery ·Taisuke Imamura, Ryo Ashida, Kenichi Urakami, Keiichi Ohshima, Katsuhiko Uesaka, Teiichi Sugiura, Yukiyasu Okamura, Katsuhisa Ohgi, Mihoko Yamada, Shimpei Otsuka, Takeshi Nagashima, Takashi Sugino, Yasuto Akiyama, Ken Yamaguchi	1
9	Mutation burden-orthogonal tumor genomic subtypes delineate responses to immune checkpoint therapy 2022 ·Journal for ImmunoTherapy of Cancer ·Shiro Takamatsu, Junzo Hamanishi, J.B. Brown, Ken Yamaguchi, Koji Yamanoi, Kosuke Murakami, Osamu Gotoh, Seiichi Mori, Masaki Mandai, Noriomi Matsumura	4
10	Peritoneal dissemination of high-grade serous ovarian cancer: pivotal roles of chromosomal instability and epigenetic dynamics 2022 ·Journal of Gynecologic Oncology ·Ikuo Konishi, Kaoru Abiko, Takuma Hayashi, Koji Yamanoi, Ryusuke Murakami, Ken Yamaguchi, Junzo Hamanishi, Tsukasa Baba, Noriomi Matsumura, Masaki Mandai	10
11	Potential Novel Ovarian Cancer Treatment Targeting Myeloid-Derived Suppressor Cells 2020 ·Takuma Hayashi, Kaoru Abiko, Ken Yamaguchi, Masaki Mandai, Ikuo Konishi	2
12	A T-cell–engaging B7-H4/CD3-bispecific Fab-scFv Antibody Targets Human Breast Cancer 2019 ·Clinical Cancer Research ·Akira Iizuka, (unknown), Tadashi Ashizawa, Ryota Kondou, Keiichi Ohshima, Takashi Sugino, Koichi Mitsuya, Nakamasa Hayashi, Yoko Nakasu, Kouji Maruyama, Ken Yamaguchi, Yasuto Akiyama	61
13	Unenhanced region on magnetic resonance imaging represents tumor progression in uterine carcinosarcoma 2017 ·Journal of Gynecologic Oncology ·(unknown), Ken Yamaguchi, Yasuhisa Kurata, Ryusuke Murakami, Kaoru Abiko, Junzo Hamanishi, Eiji Kondoh, Tsukasa Baba, Aki Kido, Ikuo Konishi, Noriomi Matsumura	4
14	Expression of Vascular Endothelial Growth Factor in Ovarian Cancer Inhibits Tumor Immunity through the Accumulation of Myeloid-Derived Suppressor Cells 2016 ·Clinical Cancer Research ·Naoki Horikawa, Kaoru Abiko, Noriomi Matsumura, Junzo Hamanishi, Tsukasa Baba, Ken Yamaguchi, Yumiko Yoshioka, Masafumi Koshiyama, Ikuo Konishi	228
15	Antitumor Effect of Programmed Death-1 (PD-1) Blockade in Humanized the NOG-MHC Double Knockout Mouse 2016 ·Clinical Cancer Research ·Tadashi Ashizawa, Akira Iizuka, (unknown), Ryota Kondou, (unknown), Haruo Miyata, Takashi Sugino, Koichi Mitsuya, Nakamasa Hayashi, Yoko Nakasu, Kouji Maruyama, Ken Yamaguchi, Ikumi Katano, Mamoru Ito, Yasuto Akiyama	77
16	Groin lymph node detection and sentinel lymph node biopsy in vulvar cancer 2016 ·Journal of Gynecologic Oncology ·(unknown), Ken Yamaguchi, Noriomi Matsumura, Hidekatsu Nakai, Yumiko Yoshioka, Eiji Kondoh, Junzo Hamanishi, Kaoru Abiko, Masafumi Koshiyama, Tsukasa Baba, Aki Kido, Masaki Mandai, Ikuo Konishi	9
17	Chemotherapy Induces Programmed Cell Death-Ligand 1 Overexpression via the Nuclear Factor-κB to Foster an Immunosuppressive Tumor Microenvironment in Ovarian Cancer breakdown → 2015 ·Cancer Research ·Peng Jin, Junzo Hamanishi, Noriomi Matsumura, Kaoru Abiko, Kumuruz Murat, Tsukasa Baba, Ken Yamaguchi, Naoki Horikawa, Yuko Hosoe, Susan K. Murphy, Ikuo Konishi, Masaki Mandai	437
18	STAT1 Drives Tumor Progression in Serous Papillary Endometrial Cancer 2014 ·Cancer Research ·Budiman Kharma, Tsukasa Baba, Noriomi Matsumura, Hyun Kang, Junzo Hamanishi, Ryusuke Murakami, (unknown), Samuel Leung, Ken Yamaguchi, Yuko Hosoe, Yumiko Yoshioka, Susan K. Murphy, Masaki Mandai, (unknown), Ikuo Konishi	62
19	PD-L1 on Tumor Cells Is Induced in Ascites and Promotes Peritoneal Dissemination of Ovarian Cancer through CTL Dysfunction 2013 ·Clinical Cancer Research ·Kaoru Abiko, Masaki Mandai, Junzo Hamanishi, Yumiko Yoshioka, Noriomi Matsumura, Tsukasa Baba, Ken Yamaguchi, Ryusuke Murakami, Ayaka Yamamoto, Budiman Kharma, Kenzo Kosaka, Ikuo Konishi	187
20	Programmed cell death 1 ligand 1 and tumor-infiltrating CD8 ⁺ T lymphocytes are prognostic factors of human ovarian cancer breakdown → 2007 ·Proceedings of the National Academy of Sciences ·Junzo Hamanishi, Masaki Mandai, Masashi Iwasaki, Taku Okazaki, Yoshimasa Tanaka, Ken Yamaguchi, Toshihiro Higuchi, Haruhiko Yagi, Kenji Takakura, Nagahiro Minato, Tasuku Honjo, Shingo Fujii	1155

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact